Oxidative stress impairs glutamate uptake in fibroblasts from patients with alzheimer's disease

Free Radical Biology and Medicine

Volumn 37, Issue 6, 2004, Pages 892-901

  Begni, Barbara ^a   Brighina, Laura ^a   Sirtori, Elena ^a   Fumagalli, Lorenzo ^a   Andreoni, Simona ^a   Beretta, Simone ^a   Oster, Thierry ^d   Malaplate Armand, Catherine ^d   Isella, Valeria ^a   Appollonio, Ildebrando ^a,b   Ferrarese, Carlo ^a,b,c  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b SAN GERARDO HOSPITAL   (Italy)

^c SCIENTIFIC INSTITUTE   (Italy)

^d INSERM   (France)

Author keywords

4 Hydroxynonenal; Alzheimer's disease; Fibroblast; Free radicals; Glutamate uptake; Glutathione

Indexed keywords

4 HYDROXYNONENAL; ACETYLCYSTEINE; ANTIOXIDANT; BUTHIONINE SULFOXIMINE; GLUTAMIC ACID; GLUTATHIONE;

ADULT; AGED; ALZHEIMER DISEASE; AMINO ACID TRANSPORT; ARTICLE; CELL CULTURE; CELL VIABILITY; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FIBROBLAST; GLUTATHIONE METABOLISM; HUMAN; LIPID PEROXIDATION; MALE; MUTATION; NERVE CELL NECROSIS; OXIDATIVE STRESS; PATHOGENICITY; PRIORITY JOURNAL; REDUCTION;

ACETYLCYSTEINE; ADENOSINE TRIPHOSPHATE; AGED; AGED, 80 AND OVER; ALDEHYDES; ALZHEIMER DISEASE; ANIMALS; ANTIOXIDANTS; CASE-CONTROL STUDIES; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DOSE-RESPONSE RELATIONSHIP, DRUG; FIBROBLASTS; FREE RADICALS; GLUTAMIC ACID; GLUTATHIONE; HUMANS; L-LACTATE DEHYDROGENASE; LIPID PEROXIDATION; MIDDLE AGED; OXIDATIVE STRESS; REACTIVE OXYGEN SPECIES; TETRAZOLIUM SALTS; THIAZOLES; TIME FACTORS;

EID: 4043050074     PISSN: 08915849     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2004.05.028     Document Type: Article

References (67)

1. Maragakis N.J., Rothstein J.D. Glutamate transporters in neurologic disease. Arch. Neurol. 58(3):2001;365-370
2. Cross A.J., Slater P., Simpson M., Royston C., Deakin J.F., Perry R.H., Perry E.K. Sodium dependent D-[3H]aspartate binding in cerebral cortex in patients with Alzheimer's and Parkinson's diseases. Neurosci. Lett. 79(1-2):1987;213-217
3. Cowburn R., Hardy J., Roberts P., Briggs R. Presynaptic and postsynaptic glutamatergic function in Alzheimer's disease. Neurosci. Lett. 86(1):1988;109-113
4. Scott H.L., Tannenberg A.E., Dodd P.R. Variant forms of neuronal glutamate transporter sites in Alzheimer's disease cerebral cortex. J. Neurochem. 64(5):1995;2193-2202
5. Masliah E., Alford M., Mallory M., Rockestain E., Moechars D., Van Leuven F. Abnormal glutamate transport function in mutant amyloid precursor protein transgenic mice. Exp. Neurol. 163(2):2000;381-387
6. Scott H.L., Pow D.V., Tannenberg A.E., Dodd P.R. Aberrant expression of the glutamate transporter excitatory amino acid transporter 1 (EAAT1) in Alzheimer's disease. J. Neurosci. 22:2002;1-5
7. Koh J.Y., Yang L.L., Cotman C.W. Beta amyloid protein increases the vulnerability of cultured cortical neurons to excitotoxic damage. Brain Res. 533:1998;315-320
8. 2+ homeostasis and cell death. J. Neurosci. 15:1995;6239-6249
9. Kanowski S., Herrmann W.M., Stephan K., Wierich W., Horr R. Proof of efficacy of the Ginkgo biloba special extract EGb 761 in outpatients suffering from mild to moderate primary degenerative dementia of the Alzheimer type or multi-infarct dementia. Pharmacopsychiatry. 29(2):1996;47-56
10. Marcus D.L., Rodriguez C., Simberkoff K., Tsai J.S., Sttrafaci J.A., Freedman M.L. Increased peroxidation and antioxidant enzyme activity in Alzheimer's disease. Exp. Neurol. 150:1998;40-44
11. Markesbery W.R., Lovell M.A. Four-hydroxynonenal, a product of lipid peroxidation, is increased in the brain in Alzheimer's disease. Neurobiol. Aging. 19(1):1998;33-36
12. Lovell M.A., Ehmann W.D., Mattson M.P., Markesbery W.R. Elevated 4-hydroxynonenal in ventricular fluid in Alzheimer's disease. Neurobiol. Aging. 18(5):1997;457-461
13. Keller J.N., Mark R.J., Bruce A.J., Blanc E., Rothstein J.D., Uchida K., Waeg G., Mattson M.P. 4-hydroxynonenal an aldehyde product of membrane lipid peroxidation, impairs glutamate transport and mitochondrial function in synaptosomes. Neuroscience. 80:1997;685-696
14. Blanc E.M., Keller J.N., Fernandez S., Mattson M.P. 4-Hydroxynonenal, a lipid peroxidation product, impairs glutamate transport in cortical astrocytes. Glia. 22(2):1998;149-160
15. Lauderback C.M., Hackett J.M., Huang F.F., Keller J.N., Szweda L.I., Markesberry W.R., Butterfield D.A. The glial glutamate transporter, GLT-1, is oxidatively modified by 4-hydroxy-2-nonenal in the Alzheimer's disease brain: the role of Aβ1-42. J. Neurochem. 78(2):2001;413-416
16. Gridley K.E., Green P.S., Simpkins J.W. Low concentrations of estradiol reduce β-amyloid (25-35)-induced toxicity, lipid peroxidation and glucose utilization in human SK-N-SH neuroblastoma cells. Brain Res. 778(1):1997;158-165
17. Shen Y.X., Xu S.Y., Wei W., Sun X.X., Liu L.H., Yang J., Dong C. The protective effects of melatonin from oxidative damage induced by amyloid β-peptide 25-35 in middle-aged rats. J. Pineal Res. 32(2):2002;85-89
18. Yatin S.M., Varadarajan S., Butterfield D.A. Vitamin E prevents Alzheimer's amyloid β-peptide (1-42)-induced neuronal protein oxidation and reactive oxygen species production. J. Alzheimers Dis. 2(2):2000;123-131
19. Omar R.A., Chyan Y.J., Andorn A.C., Poeggeler B., Robakis N.K., Pappolla M.A. Increased expression but reduced activity of antioxidant enzymes in Alzheimer's disease. J. Alzheimers Dis. 1(3):1999;139-145
20. Lovell M.A., Xie C., Markesbery W.R. Decreased glutathione transferase activity in brain and ventricular fluid in Alzheimer's disease. Neurology. 51(6):1998;1562-1566
21. Karelson E., Bogdanovic N., Garlind A., Winblad B., Zilmer K., Kullisaar T., Vihalemm T., Kairane C., Zilmer M. The cerebrocortical areas as in normal brain aging and in Alzheimer's disease: noticeable differences in the lipid peroxidation level and in antioxidant defense. Neurochem. Res. 26(4):2001;353-361
22. Mehta P.D., Pirttila T., Mehta S.P., Sersen E.A., Aisen P.S., Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid β proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 57(1):2000;100-105
23. Di Luca M., Pastorino L., Cattabeni F., Zanardi R., Scarone S., Racagni G., Smeraldi E., Perez J. Abnormal pattern of platelet APP isoforms in Alzheimer disease and Down syndrome. Arch. Neurol. 53(11):1996;1162-1166
24. Gasparini L., Benussi L., Bianchetti A., Binetti G., Curti D., Covoni S., Moraschi S., Racchi M., Trabucchi M. Energy metabolism inhibition impairs amyloid precursor protein secretion from Alzheimer's fibroblasts. Neurosci. Lett. 263(2-3):1999;197-200
25. Pratico D., Clark C.M., Lee V.M., Trojanowski J.O., Rokach J., FitzGerald G.A. Increased 8,12-iso-iPF2α-VI in Alzheimer's disease: correlation of a noninvasive index of lipid peroxidation with disease severity. Ann. Neurol. 48(5):2000;809-812
26. Cecchi C., Latorraca S., Sorbi S., Iantomasi T., Favilli F., Vicentini M.T., Liguri G. Glutathione level is altered in lymphoblasts from patients with familial Alzheimer's disease. Neurosci. Lett. 275(2):1999;152-154
27. Mecocci P., Polidori M.C., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Beal M.F. Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Arch. Neurol. 59(5):2002;794-798
28. Cecchi C., Fiorello C., Sorbi S., Latorraca S., Nacmias B., Bagnoli S., Nassi P., Liguri G. Oxidative stress and reduced antioxidant defenses in peripheral cells from familial Alzheimer's patients. Free Radic. Biol. Med. 33(10):2002;1372-1379
29. Ferrarese C., Begni B., Canevari C., Zoia C., Piolti R., Frigo M., Appollonio I., Frattola L. Glutamate uptake is decreased in platelets from Alzheimer's disease patients. Ann. Neurol. 47(5):2000;641-643
30. Begni B., Brighina L., Fumagalli L., Andreoni S., Castelli E., Francesconi C., Del Bo R., Bresolin N., Ferrarese C. Altered glutamate uptake in peripheral tissues from Down syndrome patients. Neurosci. Lett. 343(2):2003;73-76
31. Lobner D. Comparison of LDH and MTT assays for quantifying cell death: validity for neuronal apoptosis? J. Neurosci. Methods. 96(2):2000;147-152
32. Lowry J.C., Rosebrough N.J., Farr A.L., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275
33. Leroy P., Nicolas A., Thioudellet C., Oster T., Wellman M., Siest G. Rapid liquid chromatographic assay of glutathione in cultured cells. Biomed. Chromatogr. 7:1993;86-89
34. Arriza J.L., Fairman W.A., Wadiche J.I., Murdoch G.H., Kavanaugh M.P., Amara S.G. Functional comparisons of the three glutamate transporter subtypes cloned from human motor cortex. J. Neurosci. 14(9):1994;5559-5569
35. Esterbauer H., Schaur R.J., Zollner H. Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11(1):1991;81-128
36. Schaur R.J. Basic aspect of the biochemical reactivity of 4-hydroxynonenal. Mol. Aspects Med. 24:2003;149-159
37. Kristal B.S., Park B.K., Yu B.P. 4-Hydroxyhexenal is a potent inducer of the mitochondrial permeability transition. J. Biol. Chem. 271(11):1996;6033-6038
38. Masliah E., Alford M., DeTeresa R., Mallory M., Hansen L. Deficient glutamate transport is associated with neurodegeneration in Alzheimer's disease. Ann. Neurol. 40(5):1996;759-766
39. Liang Z., Valla J., Sefidvash-Hockeley S., Rogers J., Li R. Effects of estrogen treatment on glutamate uptake in cultured human astrocytes derived from cortex of Alzheimer's disease patients. J. Neurochem. 80(5):2002;807-814
40. Connolly J.P. Fibroblast models of neurological disorders: fluorescence measurement studies. Trends Pharmacol. Sci. 19(5):1998;171-177
41. Vestling M., Cedazo-Minguez A., Adem A., Wiehager B., Racchi M., Lannfelt L., Cowburn R.F. Protein kinase C and amyloid precursor protein processing in skin fibroblasts from sporadic and familial Alzheimer's disease cases. Biochim. Biophys. Acta. 1453(3):1999;341-350
42. Wang H.Y., Pisano M.R., Friedman E. Attenuated protein kinase C activity and translocation in Alzheimer's disease brain. Neurobiol. Aging. 15(3):1994;293-298
43. Govoni S., Bergamaschi S., Racchi M., Battaini F., Binetti G., Bianchetti A., Trabucchi M. Cytosol protein kinase C downregulation in fibroblasts from Alzheimer's disease patients. Neurology. 43(12):1993;2581-2586
44. Chandrasekaran K., Hatanpaa K., Brady D.R., Stoll J., Rapoport S.I. Downregulation of oxidative phosphorylation in Alzheimer disease: loss of cytochrome oxidase subunit mRNA in the hippocampus and entorhinal cortex. Brain Res. 796(1-2):1998;13-19
45. Sims N.R., Finegan J.M., Blass J.P., Bowen D.M., Neary D. Mitochondrial function in brain tissue in primary degenerative dementia. Brain Res. 436(1):1987;30-38
46. Mazzola J.L., Sivorer M.A. Reduction of glyceraldehyde-3-phosphate dehydrogenase activity in Alzheimer's disease and in Huntington's disease fibroblasts. J. Neurochem. 76(2):2001;442-449
47. Zoia C., Cogliati T., Tagliabue E., Cavaletti G., Sala G., Galimberti G., Rivolta I., Rossi V., Frattola L., Ferrarese C. Glutamate transporters in platelets: EAAT1 decrease in aging and in Alzheimer's disease. Neurobiol. Aging. 25(2):2004;149-157
48. Trotti D., Nussberger S., Volterra A., Hediger M.A. Differential modulation of the uptake currents by redox interconversion of cysteine residues in the human neuronal glutamate transporter EAAC1. Eur. J. Neurosci. 9(10):1997;2207-2212
49. Aksenov M.Y., Aksenova M.V., Butterfield D.A., Geddes J.W., Markesbery W.R. Protein oxidation in the brain in Alzheimer's disease. Neuroscience. 103(2):2001;373-383
50. Smith M.A., Richey Harris P.L., Sayre L.M., Beckman J.S., Perry G. Widespread peroxynitrite-mediated damage in Alzheimer's disease. J. Neurosci. 17(8):1997;2653-2657
51. Lyras L., Perry R.H., Perry E.K., Ince P.G., Jenner A., Jenner P., Halliwell B. Oxidative damage to proteins, lipids, and DNA in cortical brain regions from patients with dementia with Lewy bodies. J. Neurochem. 71(1):1998;302-312
52. Conrad C.C., Marshall P.L., Talent J.M., Malakowsky C.A., Choi J., Gracy R.W. Oxidized proteins in Alzheimer's plasma. Biochem. Biophys. Res. Commun. 275(2):2000;678-681
53. Gibson G.E., Zhang H., Sheu K.R., Park L.C. Differential alterations in antioxidant capacity in cells from Alzheimer patients. Biochim. Biophys. Acta. 1502(3):2000;319-329
54. Selley M.L., Close D.R., Stern S.E. The effect of increased concentrations of homocysteine on the concentration of (E)-4-hydroxy-2-nonenal in the plasma and cerebrospinal fluid of patients with Alzheimer's disease. Neurobiol. Aging. 23(3):2002;383-388
55. Mark R.J., Lovell M.A., Markesbery W.R., Uchida K., Mattson M.P. A role for 4-hydroxynonenal, an aldehydic product of lipid peroxidation, in disruption of ion homeostasis and neuronal death induced by amyloid β-peptide. J. Neurochem. 68(1):1997;255-264
56. +-dependent high-affinity uptake of L-glutamate in cultured fibroblasts. FEBS Lett. 300(3):1992;203-207
57. Cooper B., Chebib M., Shen J., King N.J., Darvey I.G., Kuchel P.W., Rothstein J.D., Balcar V.J. Structural selectivity and molecular nature of L-glutamate transport in cultured human fibroblasts. Arch. Biochem. Biophys. 353(2):1998;356-364
58. Trotti D., Rossi D., Gjesdal O., Levy L.M., Racagni G., Danbolt N.C., Volterra A. Peroxynitrite inhibits glutamate transporter subtypes. J. Biol. Chem. 271:1996;5976-5979
59. Mark R.J., Pang Z., Geddes J.W., Uchida K., Mattson M.P. Amyloid β-peptide impairs glucose transport in hippocampal and cortical neurons: involvement of membrane lipid peroxidation. J. Neurosci. 17(3):1997;1046-1054
60. Casley C.S., Land J.M., Sharpe M.A., Clark J.B., Duchen M.R., Canevari L. Beta-amyloid fragment 25-35 causes mitochondrial dysfunction in primary cortical neurons. Neurobiol. Dis. 10(3):2002;258-267
61. Gridley K.E., Green P.S., Simpkins J.W. A novel, synergistic interaction between 17 β-estradiol and glutathione in the protection of neurons against β-amyloid 25-35-induced toxicity in vitro. Mol. Pharmacol. 54(5):1998;874-880
62. Nakajima A., Yamada K., Zou L.B., Yan Y., Mizuno M., Nabeshima T. Interleukin-6 protects PC12 cells from 4-hydroxynonenal-induced cytotoxicity by increasing intracellular glutathione levels. Free Radic. Biol. Med. 32(12):2002;1324-1332
63. Trotti D., Danbolt N.C., Volterra A. Glutamate transporters are oxidant-vulnerable: a molecular link between oxidative and excitotoxic neurodegeneration? Trends Pharmacol. Sci. 19(8):1998;328-334
64. Winterbourn C.C., Metodiewa D. Reactivity of biologically important thiol compounds with superoxide and hydrogen peroxide. Free Radic. Biol. Med. 27(3-4):1999;322-328
65. Drake J., Kanski J., Varadarajan S., Tsoras M., Butterfield D.A. Elevation of brain glutathione by γ-glutamylcysteine ethyl ester protects against peroxynitrite-induced oxidative stress. J. Neurosci. Res. 68(6):2002;776-784
66. Ou J.J., Zhang Y., Montine T.J. In vivo assessment of lipid peroxidation products associated with age-related neurodegenerative diseases. Exp. Neurol. 175(2):2002;363-369
67. Pocernich C.B., Cardin A.L., Racine C.L., Lauderback C.M., Butterfield D.A. Glutathione elevation and its protective role in acrolein-induced protein damage in synaptosomal membranes: relevance to brain lipid peroxidation in neurodegenerative disease. Neurochem. Int. 39(2):2001;141-149